Proteomics market is expected to experience significant growth driven by increasing research activities in drug discovery and development, rising prevalence of chronic and infectious diseases, and technological advancements in proteomics techniques. The growing demand for personalized medicine and biomarker discovery for early disease diagnosis are also contributing to market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Application, Technology, End User |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Thermo Fisher scientific, Alumna incorporated, Creative proteomics, GE healthcare, Integrated proteomics applications |
The high cost of proteomics instruments and lack of skilled professionals are major restraints hindering market growth. Additionally, the complexity and time-consuming nature of proteomics data analysis and interpretation pose challenges for market players, limiting the adoption of proteomics technologies.